Sodium chlorite


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:3803340IVR1 mg/L -No significant effects observed-
IVR100 mg/L 100 mg/LDecrease in T4 levelsMetabolic endocrine-mediated perturbations
IVR100 mg/L 100 mg/LAffects sperm motilityReproductive endocrine-mediated perturbations
IVR10 mg/L -No significant effects observed-
IVR100 mg/L 100 mg/LDecrease in T3 levelsMetabolic endocrine-mediated perturbations
IVR100 mg/L 100 mg/LAbnormal sperm morphologyReproductive endocrine-mediated perturbations
IVR500 mg/L 500 mg/LDecrease in T4 levelsMetabolic endocrine-mediated perturbations
IVR500 mg/L 500 mg/LDecrease in T3 levelsMetabolic endocrine-mediated perturbations
IVR500 mg/L 500 mg/LAbnormal sperm morphologyReproductive endocrine-mediated perturbations
IVR500 mg/L 500 mg/LAffects sperm motilityReproductive endocrine-mediated perturbations
PMID:7151764IVR200 mg/kg 200 mg/kgAlteration in vaginal morphologyReproductive endocrine-mediated perturbations
IVR200 mg/kg 200 mg/kgCauses vaginal bleedingReproductive endocrine-mediated perturbations
IVR10 mg/kg 10 mg/kgAffects litter sizeReproductive endocrine-mediated perturbations
IVR0.1 % -No significant effects observed-
IVR0.5 % -No significant effects observed-
IVR50 mg/kg 50 mg/kgAlteration in vaginal morphologyReproductive endocrine-mediated perturbations
IVR50 mg/kg 50 mg/kgCauses vaginal bleedingReproductive endocrine-mediated perturbations
IVR20 mg/kg 20 mg/kgAffects litter sizeReproductive endocrine-mediated perturbations
IVR20 mg/kg 20 mg/kgCauses vaginal bleedingReproductive endocrine-mediated perturbations
IVR20 mg/kg 20 mg/kgAlteration in vaginal morphologyReproductive endocrine-mediated perturbations
IVR2 % 2 %Changes in haemocrit valuesImmunological endocrine-mediated perturbations
IVR2 % 2 %Affects litter sizeReproductive endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.